Author:
Volkenandt Matthias,Schmid-Wendtner Monika,Hauschild Axel
Publisher
Springer Berlin Heidelberg
Reference15 articles.
1. Balch CM, Cascinelli N, Sim F, Soong S. (1998) Elective lymph node Dissection: Results of prospective randomized surgical trials. In: Balch CM, Houghton AN, Sober AJ, Soong S (eds) Cutaneous Melanoma 3. Auflage. Quality Medical Publishing Inc, St. Louis, Missouri pp 209–225
2. Balch CM, Maddox WA (1978) The logic of adjunctive therapy in surgical patients with resectable cancer. South Med J 71: 951–955
3. Garbe C (Hrsg) (1998) Diagnostische und therapeutische Standards in der Dermatologischen Onkologie. Zuckschwerdt, München
4. Gershenwald JE, Colome MI, Lee JE et al. (1998) Patterns of recurrence following a negative Sentinel Lymph Node Biopsy in 243 Patients With Stage I or II Melanoma. J Clin Oncol 16: 2253–2260
5. Grob JJ, Dreno B, de la Salmonière P et al. (1998) Randomised trial of interferon a-2a as adjuvant therapy in resected primary melanoma thicker than 1,5 mm without clinically detectable node metastases. Lancet 351: 1905–1910